{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:26:49Z","timestamp":1771064809588,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.amjmed.2020.05.029","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T11:03:35Z","timestamp":1593255815000},"page":"e641-e658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5169-620X","authenticated-orcid":false,"given":"Sabrina A.","family":"Assoumou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayla","family":"Nolen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesl","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golnaz","family":"Eftekhari Yazdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William W.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth H.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9155-7733","authenticated-orcid":false,"given":"Jon","family":"Puro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4490-9246","authenticated-orcid":false,"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-5515","authenticated-orcid":false,"given":"Joshua A.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin P.","family":"Linas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.amjmed.2020.05.029_bib0001","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 years \u2013 Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012","volume":"64","author":"Zibbell","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.amjmed.2020.05.029_bib0002","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.amjmed.2020.05.029_bib0003","first-page":"358","article-title":"Notes from the field : hepatitis C virus infections among young adults\u2013rural Wisconsin, 2010","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"42","key":"10.1016\/j.amjmed.2020.05.029_bib0004","first-page":"1457","article-title":"Notes from the field: risk factors for hepatitis C virus infections among young adults\u2013Massachusetts, 2010","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0005","unstructured":"National Association of Community Health Centers. America's Health Centers. Fact Sheet March 2016. Accessed on January 6, 2019. Available at: http:\/\/www.nachc.org\/wp-content\/uploads\/2015\/06\/Americas-Health-Centers-March-2016.pdf."},{"issue":"4","key":"10.1016\/j.amjmed.2020.05.029_bib0006","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/amiajnl-2014-002744","article-title":"The ADVANCE network: accelerating data value across a national community health center network","volume":"21","author":"DeVoe","year":"2014","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0007","unstructured":"National Association of Community Health Centers. Research Fact Sheets and Infographics. Available at: http:\/\/www.nachc.org\/research-and-data\/research-fact-sheets-and-infographics\/. Accessed April 19, 2020."},{"key":"10.1016\/j.amjmed.2020.05.029_bib0008","article-title":"The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings","author":"Assoumou","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0009","article-title":"Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement","author":"Force","year":"2020","journal-title":"JAMA"},{"issue":"1 Suppl 1","key":"10.1016\/j.amjmed.2020.05.029_bib0010","article-title":"Counselor- versus provider-based HIV screening in the emergency department: results from the universal screening for HIV infection in the emergency room (USHER) randomized controlled trial","volume":"58","author":"Walensky","year":"2011","journal-title":"Ann Emerg Med"},{"issue":"9","key":"10.1016\/j.amjmed.2020.05.029_bib0011","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/M14-1313","article-title":"The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection","volume":"162","author":"Linas","year":"2015","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.amjmed.2020.05.029_bib0012","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7326\/0003-4819-159-5-201309030-00021","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection","volume":"159","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"issue":"RR-4","key":"10.1016\/j.amjmed.2020.05.029_bib0013","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1016\/j.amjmed.2020.05.029_bib0014","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1377\/hlthaff.2017.0684","article-title":"Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations","volume":"36","author":"Barocas","year":"2017","journal-title":"Health Aff (Millwood)"},{"issue":"27","key":"10.1016\/j.amjmed.2020.05.029_bib0015","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa1512614","article-title":"Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis","volume":"373","author":"Curry","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2020.05.029_bib0016","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jhep.2017.03.039","article-title":"Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis","volume":"67","author":"Kwo","year":"2017","journal-title":"J Hepatol"},{"issue":"22","key":"10.1016\/j.amjmed.2020.05.029_bib0017","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection","volume":"376","author":"Bourliere","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2020.05.029_bib0018","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1097\/MCG.0b013e3181e12c09","article-title":"Direct economic burden of chronic hepatitis C virus in a United States managed care population","volume":"45","author":"Davis","year":"2011","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.amjmed.2020.05.029_bib0019","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ajg.2009.31","article-title":"Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study","volume":"104","author":"Bruno","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2014.10.025","article-title":"Trends in use of health care and HIV prevention services for persons who inject drugs in San Francisco: Results from National HIV Behavioral Surveillance 2005\u20132012","volume":"146","author":"Coffin","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1016\/j.amjmed.2020.05.029_bib0021","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.drugpo.2015.07.004","article-title":"Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis","volume":"26","author":"Smith","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"7","key":"10.1016\/j.amjmed.2020.05.029_bib0022","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/aje\/kwg209","article-title":"Longitudinal Patterns of Drug Injection Behavior in the ALIVE Study Cohort,1988\u20132000: Description and Determinants","volume":"158","author":"Galai","year":"2003","journal-title":"American Journal of Epidemiology"},{"issue":"7","key":"10.1016\/j.amjmed.2020.05.029_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101554","article-title":"The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis","volume":"9","author":"Yehia","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.amjmed.2020.05.029_bib0024","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/M16-0065","article-title":"Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis","volume":"165","author":"Freiman","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0025","series-title":"Summary report for the HIV Department of the World Health Organization to inform the WHO Hepatitis Screening Guidelines","article-title":"PICO 4: Diagnostic strategies for Hepatitis C antibody detection: A meta-analysis and review of the literature","author":"Boeras","year":"2015"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0026","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). 2016 National Survey on Drug Use and Health (NSDUH). Accessed on February 2nd, 2018. Available at: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabs-2016\/NSDUH-DetTabs-2016.pdf"},{"issue":"6","key":"10.1016\/j.amjmed.2020.05.029_bib0027","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.dld.2011.12.014","article-title":"Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk","volume":"44","author":"Litwin","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.amjmed.2020.05.029_bib0028","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0272989X06290495","article-title":"Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States","volume":"26","author":"Sullivan","year":"2006","journal-title":"Medical decision making : an international journal of the Society for Medical Decision Making"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0029","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0272989X08315240","article-title":"Health-State Utilities in Liver Disease: A Systematic Review","volume":"28","author":"McLernon","year":"2008","journal-title":"Medical Decision Making"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0030","unstructured":"United States Department of Health and Human Services Center for Medicare Services. Physician Fee Schedule. Available from: http:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/PhysicianFeeSched\/index.html?redirect=\/PhysicianFeeSched. Accessed August 3rd, 2017."},{"key":"10.1016\/j.amjmed.2020.05.029_bib0031","series-title":"Cost-Effectiveness in Health and Medicine","author":"Neumann","year":"2016"},{"issue":"10","key":"10.1016\/j.amjmed.2020.05.029_bib0032","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40273-017-0560-y","article-title":"ICER's Revised Value Assessment Framework for 2017-2019: A Critique","volume":"35","author":"Neumann","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1016\/j.amjmed.2020.05.029_bib0033","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2105\/AJPH.2013.301282","article-title":"Prevalence of HCV infection among clients in community-based health settings in Hawaii, 2002-2010: assessing risk factors","volume":"104","author":"Porter","year":"2014","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.amjmed.2020.05.029_bib0034","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/add.12863","article-title":"Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006\u201310","volume":"110","author":"Evans","year":"2015","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.amjmed.2020.05.029_bib0035","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/infdis\/jiv220","article-title":"Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection\u2013the InC3 Study","volume":"212","author":"Sacks-Davis","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.amjmed.2020.05.029_bib0036","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"Journal of Viral Hepatitis"},{"issue":"6","key":"10.1016\/j.amjmed.2020.05.029_bib0037","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2105\/AJPH.2011.300460","article-title":"Implementing Rapid HIV Testing With or Without Risk-Reduction Counseling in Drug Treatment Centers: Results of a Randomized Trial","volume":"102","author":"Metsch","year":"2012","journal-title":"American Journal of Public Health"},{"issue":"6","key":"10.1016\/j.amjmed.2020.05.029_bib0038","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2105\/AJPH.2011.300460","article-title":"Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial","volume":"102","author":"Metsch","year":"2012","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.amjmed.2020.05.029_bib0039","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/003335490712200105","article-title":"Medical Care and Alcohol Use after Testing Hepatitis C Antibody Positive at STD Clinic and HIV Test Site Screening Programs","volume":"122","author":"Mark","year":"2007","journal-title":"Public Health Rep"},{"issue":"3","key":"10.1016\/j.amjmed.2020.05.029_bib0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/hep.27584","article-title":"The continuum of hepatitis C testing and care","volume":"61","author":"Viner","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0041","unstructured":"United States Department of Labor. National Compensation Survey. Available at: www.bls.gov\/data. (accessed and archived at http:\/\/www.webcitation.org\/6MeG8PF6B on 12 April 2018)."},{"issue":"1","key":"10.1016\/j.amjmed.2020.05.029_bib0042","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/add.12754","article-title":"Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs","volume":"110","author":"Schackman","year":"2015","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.amjmed.2020.05.029_bib0043","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.drugpo.2015.07.004","article-title":"Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis","volume":"26","author":"Smith","year":"2015","journal-title":"Int J Drug Policy"},{"issue":"6","key":"10.1016\/j.amjmed.2020.05.029_bib0044","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/jvh.12506","article-title":"Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network","volume":"23","author":"Younossi","year":"2016","journal-title":"Journal of Viral Hepatitis"},{"issue":"4","key":"10.1016\/j.amjmed.2020.05.029_bib0045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa1702417","article-title":"Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection","volume":"378","author":"Zeuzem","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0046","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1512610","article-title":"Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection","author":"Feld","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2020.05.029_bib0047","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/hep.29130","article-title":"Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in direct-acting antiviral-experienced patients with genotype 1 hepatitis C virus","volume":"65","author":"Lawitz","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0048","unstructured":"Pharmaceutical Catalag. In: Affairs USDoV, ed. National Acquisition Center (CCST); 2017."},{"key":"10.1016\/j.amjmed.2020.05.029_bib0049","series-title":"European Association for the Study of the Liver, April 24-28","article-title":"Health-related quality of life among genotype 1 treatment experienced chronic hepatitis C patients: Post-hoc anlyses of data from the Realize clinical trial","author":"Sherman","year":"2013"},{"issue":"6","key":"10.1016\/j.amjmed.2020.05.029_bib0050","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2105\/AJPH.2012.301129","article-title":"Missed opportunities for hepatitis C testing in opioid treatment programs","volume":"103","author":"Frimpong","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amjmed.2020.05.029_bib0051","series-title":"Centers for Disease Control and Prevention [Internet]","year":"2016"},{"issue":"3","key":"10.1016\/j.amjmed.2020.05.029_bib0052","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320305271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934320305271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:21:02Z","timestamp":1757582462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934320305271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0002934320305271"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.05.029","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2020.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}